Skip to main content
OpenTrials
Completed

NCT Number: NCT04455516

Meniscus Repair With Simultaneous ACL Reconstruction: Clinical Outcomes,Failure Rates And Subsequent Processing

Our study has explored the causes of failure of meniscus repair and investigated the clinical effects of partial meniscectomy when meniscus repair failed.

Completed

Looking for future studies?

Notify Me

Key information

Age range

13 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Peking University Third Hospital

Beijing, Beijing Municipality, 100191, China

About this study

Background: Meniscus repair performed during ACL reconstruction may fail and the subsequent treatment includes revision meniscal repair or partial meniscectomy.

Purpose: To retrospectively analyze the clinical outcomes of meniscus repair with simultaneous anterior cruciate ligament (ACL) reconstruction and explore the causes of failure of meniscus repair.

Methods: From May 2013 to July 2018, the clinical data of 165 patients who were treated with meniscus surgery and simultaneous ACL reconstruction by the same doctor, including 69 cases of meniscus repair (repair group) and 96 cases of partial meniscectomy (partial meniscectomy group), were retrospectively analyzed. The 69 patients of the repair group were divided into the nonfailure group (62 cases) and the failure group (7 cases) depending on the repair effect. The average follow-up period was 38 (±10.5) months. Postoperative outcomes of the repair group and the partial meniscectomy group were compared. General conditions and postoperative outcomes of the failure group and the nonfailure group were compared. Seven patients in the failure group who underwent second arthroscopy were followed up for 30 (±17.4) months, and their postoperative outcomes were summarized.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with intraoperatively confirmed ACL rupture combined with medial, lateral, or medial and lateral meniscal injury;
  • age <60 years
  • no history of previous ipsilateral knee meniscal injury.

Exclusion criteria

  • ACL rupture associated with fracture, collateral ligament injury, or complex ligament injury;
  • a history of knee surgery;
  • a significant degree of osteoarthritis.

Treatment and study plan

Meniscus repair; partial meniscectomy

Procedure

69 cases of meniscus repair (repair group) and 96 cases of partial meniscectomy (partial meniscectomy group), were retrospectively analyzed. The 69 patients of the repair group were divided into the nonfailure group (62 cases) and the failure group (7 cases) depending on the repair effect.

Primary outcomes

  1. The result of partial meniscus resection

    Time frame: Two years after the surgery

    Clinical signs were assessed after the surgery, including swelling of the joint, tenderness at the joint line, locked-in syndrome, and positive McMurray's sign.

  2. International Knee Documentation Committee(IKDC)scores

    Time frame: Two years after the surgery

    The minimum is 0, the maximum is 100, and the higher the score, the better the result

  3. Visual analog scale (VAS) scores

    Time frame: Two years after the surgery

    The minimum is 0, the maximum is 10, and the higher the score, the worse the result

  4. Lysholm scores

    Time frame: Two years after the surgery

    The minimum is 0, the maximum is 100, and the higher the score, the better the result

Sponsors and collaborators

Lead sponsor

Peking University Third Hospital

Other

Registry information

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Jul 2, 2020
Registry last updated
Jul 7, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.